Different diagnostic value of p40 in benign and malignant lesions of the prostate
10.3760/cma.j.issn.1006-9801.2014.12.010
- VernacularTitle:p40检测在前列腺良恶性病变鉴别诊断中的价值
- Author:
Yongsheng ZHANG
;
Liping ZHANG
;
Xilin LIU
;
Jie HAN
;
Xiaoling ZHU
;
Ping GAO
- Publication Type:Journal Article
- Keywords:
Prostatic hyperplasia;
Prostatic neoplasms;
p40;
p63;
p504s;
Diagnosis,differential
- From:
Cancer Research and Clinic
2014;26(12):827-829,833
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the expression of p40 (ANp63),p504s and their diagnostic value in benign and malignant lesions of the prostate,also to compare with the expression of p63.Methods The expression of p40 (ANp63),p63 and p504s in 92 cases of benign prostatic hyperplasia and 67 cases of prostatic carcinoma were detected by immunohistochemical MaxVision method.Results p40 and p63 were positive in 95.7 ％ (88/92) and 87.0 ％ (80/92) of benign prostatic hyperplasia,and the intermittent and low expression in p63 were more common than those in p40.The positive expression rate of p40 was obviously higher than that of p63 in benign prostatic hyperplasia (x2 =4.381,P ＜ 0.05).Both p40 and p63 showed no expression in prostatic carcinoma,but p63 appeared with abnormal cytoplasmic staining in many cases of cancer cells,which was 17.9 ％ (12/67).The specificity of combined detection of p40 and p504s in the diagnosis of benign prostatic hyperplasia and prostate carcinoma was as high as 100 ％.Conclusion p40 is more sensitive than p63 in prostate basal cells.Combined detection of p40 and p504s is valuable to distinguish poorly differentiated benign prostatic hyperplasia from prostatic carcinoma.
